L Furlan, B Caramelli - The Lancet Regional Health–Americas, 2021 - thelancet.com
… a prophylaxis and earlytreatment medication against Covid-19 by the “Front Line COVID-19 Critical Care (FLCCC) Alliance,” an American medical organisation created in early 2020. …
C Stasi, S Fallani, F Voller, C Silvestri - European journal of pharmacology, 2020 - Elsevier
… The results of the study suggest starting remdesivir treatmentearly … early stages of COVID-19, one or a combination of antiviral agents could be used as a prophylactic or earlytreatment …
PS Kim, SW Read, AS Fauci - Jama, 2020 - jamanetwork.com
… , are under investigation for earlytreatment of COVID-19. These investigations have not yet … Examples of antivirals in trials for earlytreatment of COVID-19 are MK-4482 (EIDD-2801), …
… and AZ are the two most effective treatments among available therapies for COVID-19 [18]. Here, we report a retrospective evaluation of 1061 new COVID-19 patients, treated for at least …
… recommends treatment with a single … treatment within 48 hours after the onset of illness.We hypothesize that, on the basis of the results of the trial conducted by Beigel et al., much earlier …
A Gupta, Y Gonzalez-Rojas, E Juarez… - … England Journal of …, 2021 - Mass Medical Soc
… of Covid-19 in high-risk patients early in the … coronavirus disease 2019 (Covid-19) during the global pandemic. In the United States alone, an estimated 960,000 to 2.4 million Covid-19–…
G Reis, EASM Silva, DCM Silva… - … England Journal of …, 2022 - Mass Medical Soc
… of the efficacy of repurposed treatments for Covid-19 among adult outpatients at high risk for … Brazil in order to simultaneously test potential treatments for earlyCovid-19 with the use of a …
… However, the trial was halted early due to the decrease in COVID-19 patients in China during the study period, which could have contributed to the study being underpowered to detect …
G Reis, EAS Moreira Silva… - … England Journal of …, 2023 - Mass Medical Soc
… treatments, we examined the effect of pegylated interferon lambda on the composite outcome of Covid-19–… in time to death or hospitalization due to Covid-19 (hazard ratio, 0.59; 95% …